Research News

In trying to identify those factors that ultimately determine whether the brain cells remain alive or die off following cardiac arrest, Dr. Hui-Chao (Reggie) Lee discovered a novel enzyme in the brain that occurs much more often in brain neurons that are susceptible to reduced blood flow.

Psych Congress Network - Drs. Alan David Kaye and Elyse Cornett Bradley, professor and assistant professor, respectively, in the Department of Anesthesiology at LSUHS, discuss prevention-based TD treatment.

KTAL6 - The new Biological Safety Level three laboratory is currently being built at LSU Health Shreveport. It will allow the institution to do more research on infectious diseases. According to Chris Kevil, the Vice Chancellor for Research, the idea came during the height of the coronavirus pandemic.

On Thursday, February 23, 2023 LSU Health Shreveport (LSUHS) held the 5th Annual Research Celebration, where members of the community and LSUHS employees and students were invited to hear about the past year's accomplishments of the LSU Health Shreveport Office for Research.

LSUHS has partnered with The Michael J. Fox Foundation for Parkinson’s Research to become one of five sites participating in the Black and African American Connections to Parkinson’s Disease study.

Shreveport Times - Dr. Wayne Orr, Professor and Director of the Center for Cardiovascular Diseases and Sciences said, "the Center is a group of faculty members across multiple departments who work together to build a nationally competitive research group here in Shreveport."

Earlier this week, CCDS hosted the 2nd Annual Feist Cardiovascular Research Symposium. The symposium concluded with a poster session and awards presentation.

Medscape - Alexandre Malek, MD, assistant professor of medicine at LSUHS, pointed to "a growing number of preclinical studies evaluating the role of vaccines as adjunct to immunotherapy to overcome cancer resistance by converting cold tumors to hot." That research includes a study of a seasonal influenza vaccine and another of adenoviral based-vaccines.

Louisiana Radio Network - After a recent report from the LSUHS Louisiana Addiction Research Center showing Shreveport’s wastewater contained double the amount of methamphetamine than anywhere else in the country, many were shocked. 

National and Local News Report: LSUHS is now enrolling participants in a Phase 3 clinical trial to compare the effectiveness of standard flu vaccine to an investigational mRNA flu vaccine until mid-December. 

LSUHS Louisiana Addiction Research Center hosted a meeting on Wednesday, Nov. 9, to discuss methamphetamine as an emerging drug threat in our region. Local law enforcement and community leaders were invited to have an open conversation and share information on drug problems in the region and determine how to raise awareness.

Dr. Chris Kevil’s laboratory at LSUHS has discovered that a clinically approved cyclodextrin-based drug called Sugammadex can act as a hydrogen sulfide donor that restores vasoactive hydrogen. This innovation has already gone through initial in vivo testing with promising results.

“Medicine in general is considerably complex and neurosurgery is extremely complex, with cavernous malformations among the most difficult to manage,” said Dr. Caleb Stewart, neurosurgeon at LSUHS. LSUHS, LSUS, Ochsner Health, and collaborators in Australia are now leveraging big data science and artificial intelligence (AI) to solve this challenge and improve care for patients.

The LSU Health Shreveport Department of Otolaryngology/Head & Neck Surgery led by Chair Dr. Cherie-Ann Nathan has received notification of manuscript CCR-21-4290R1 being selected for publication in Clinical Cancer Research, a journal of the American Association for Cancer Research.

Medscape - Dr. Jeremy Kamil, Associate Professor of Microbiology and Immunology at LSUHS talks with Medscape about the importance of virology in addressing concerns over hot topic viruses.